Payette completes 223,000 s/f biomedical research building

Payette, a leading architectural design firm specializing in complex buildings for medical and scientific research, academic teaching, and healthcare, has completed the Michael F. Price Center for Genetic and Translational Medicine/ Harold and Muriel Block Research Pavilion at Albert Einstein College of Medicine of Yeshiva University. The 223,000 s/f biomedical research building is the newest addition to the College of Medicine's campus. The building's site adds 10 acres to Einstein, bringing the total size of its campus to almost 40 acres. Each floor is organized into two research wings containing 16-bench wet laboratories. One wing on each floor houses shared research facilities such as bioinformatics, gene targeting, histopathology, phenotyping, imaging, human genetics, chemical and structural genomics that can be utilized by researchers throughout the building. On each floor, the research wings meet at a common area that includes an open lounge and large conference room available to the entire floor. Lab utilities are organized in a modular, repetitive fashion to allow maximum flexibility and adaptability as research needs change over time. "The research environment of the Price Center ushers in the genomic age of medicine for Einstein," said Christopher Baylow, AIA, associate principal at Payette. "Open labs and shared support spaces have the benefit of inspiring interaction and creative exchange by researchers working on similar types of projects. The Price Center/ Block Research Pavilion responds to these needs by creating an open, friendly environment that supports the interaction of research, teaching and clinical applications. We were also cognizant of the need to provide a flexible infrastructure to respond to changing research needs and protocols." With the completion of the Michael F. Price Center for Genetic and Translational Medicine/ Harold and Muriel Block Research Pavilion, the Albert Einstein College of Medicine of Yeshiva University will continue its leadership of discovery opportunities in the biomedical sciences.